... Estimating the world cancer
burden: Globocan 2000. Int J Cancer 2001, 94 :153-156.
2. Non -small CellLungCancer Collaborative Group: Chemotherapy
in non smallcelllung cancer: a meta-analysis ... advanced non -small-
cell lung cancer: a phase III trial of the European Organiza-
tion for Research and Treatment of CancerLung Cancer
Group – EORTC 0 897 5. J Clin Oncol 2003, 21: 390 9- 391 7.
15. Gasperi-Campani ... randomized clinical tri-
als. BMJ 199 5, 311: 899 -90 9.
3. Bunn PA, Kelly K: New chemotherapeutic agents prolong sur-
vival and improve quality of life in non -small celllung cancer:
a review of the literature...
... sensitivity
overall 92 %
delE746-A750 Ab 63% 22.86% 81.1% 99 % 84.6% 79%
l858r Ab 100% 75% 97 % 95 .2% 83%
IHC specificity
overall 99 %
delE746-A750 Ab 100% 92 % 100% 40% 98 .8%
L858R Ab 100% 96 .6% 36% 98 .8%
Simonetti ... Non -small- celllungcancer harbouring mutations in the EGFR
kinase domain. Clin Transl Oncol 2010, 12:75-80.
9. Gazdar AF: Activating and resistance mutations of EGFR in non -small- cell
lung cancer: ... inactivated at 95 °C for
10 min, and the cell extract submitted to PCR. DNA
from the cell line PC -9 was used as a mutated control
for exon 19, and wt control for exons 20 and 21. DNA
from the H 197 5 cell...
... are often divided
into two broad categories: smallcelllungcancer (SCLC) and non -small celllungcancer (NSCLC). All major
histological types of lungcancer are associated with smoking, although ... as a risk marker of lungcancer in Taiwan. Cancer 2003,
97 :1558-1563.
11. Klein F, Amin Kotb WF, Petersen I: Incidence of human papilloma virus in
lung cancer. LungCancer 20 09, 65:13-18.
12. Zochbauer-Muller ... A primary xenograft model of small- celllungcancer reveals
irreversible changes in gene expression imposed by culture in vitro.
Cancer Res 20 09, 69( 8):3364-3373.
19. Schaffer BE, Park KS, Yiu...
... continue treatment.
Introduction
In non -small celllungcancer (NSCLC), mediastinal
lymphnode involvement comprises a wide spectrum of
severity. In fact, while 9% of patients with IIIA-N2
NSCLC is ... Carteni’
1
Abstract
Background: Defining the optimal treatment for patients with inoperable non smallcelllungcancer (NSCLC),
presenting with metastatic mediastinal lymph nodes, is challenging. Nevertheless, ... induced by
first-line chemotherapy with single agent
docetaxel in a patient with advanced non small
celllung cancer
Ferdinando Riccardi
1*
, Giuseppe Di Lorenzo
1
, Carlo Buonerba
1
, Guglielmo Monaco
2
,...
... Stereotactic Body Rad iotherapy, Oligometastases, Non -Small CellLung Cancer
Background
Non -small celllungcancer (NSCLC) is the leading
cause of cancer mortality in the United States [1].
Patients ... Hepatic Colorectal Metastases. Ann
surg 2002, 235:7 59- 766.
13. Sternberg DI, Sonett jr: Surgical Therapy of Lung Metastases. Semin Oncol
2007, 133 :96 7 -97 2.
Cheruvu et al. Radiation Oncology 2011, 6:80
http://www.ro-journal.com/content/6/1/80
Page ... Open Access
Comparison of outcomes in patients with stage III
versus limited stage IV non -small celllung cancer
Praveena Cheruvu
1
, Su K Metcalfe
1
, Justin Metcalfe
1
, Yuhchyau Chen
1
, Paul...
... radiotherapy for stage I
non -small celllung cancer. Radiother Oncol 2007, 85:4 29- 434.
39. Sinha B, McGarry RC: Stereotactic body radiotherapy for bilat-
eral primary lung cancers: the Indiana university ... with
operable lung cancer.
A randomized phase III trial of Radiosurgery Or Surgery
for operable Early stage (stage 1A) non -small cell Lung
cancer (ROSEL, ClinicalTrials.gov ID = NCT0068 798 6)
has been ... options for stage I
non -small celllung cancer. Oncologist 2008, 13:3 09- 3 19.
41. Brock J, Ashley S, Bedford J, Nioutsikou E, Partridge M, Brada M:
Review of Hypofractionated Small Volume Radiotherapy...
... of occult micrometas-
tases in lymph nodes of patients with non -small- celllung car-
cinoma. J Natl Cancer Inst 199 3, 85: 493 - 498 .
17. Herth FJ, Eberhardt R, Krasnik M, Ernst A: Endobronchial ... III non -small celllung cancer? An analysis of recur-
rences in a phase II study of induction chemotherapy and
involved-field radiotherapy. Int J Radiat Oncol Biol Phys 2002,
54(4) :99 9-1006.
10. ... survival of patients with unre-
sectable non-oat cell carcinoma of the lung: report by the
Radiation Therapy Oncology Group. Cancer 198 2,
50:1 091 -1 099 .
2. Bradley J, Thorstad W, Mutic S, Miller TR,...
... glands [8]. Similar
findings were made for non -small- celllung cancer
(NSCLC), where a continuous tumor regression during
radiotherapy was observed [9] .
This continuous tumor regression during radiotherapy
makes ... Radiother Oncol 20 09, 91 :288- 295 .
6. Sonke JJ, Lebesque J, van Herk M: Variability of four-dimensional
computed tomography patient models. Int J Radiat Oncol Biol
Phys 2008, 70: 590 - 598 .
7. Guckenberger ... during
fractionated radiotherapy for head-and-neck cancer using an
integrated CT/linear accelerator system. Int J Radiat Oncol Biol
Phys 2004, 59: 960 -97 0.
9. Kupelian PA, Ramsey C, Meeks SL, Willough...